Kevin Gorman | Chief Executive Officer |
Jane Sorensen | Investor Relations |
Tim Coughlin | Vice President-Finance |
Eric Benevich | Chief Commercial Officer |
Chris O'Brien | Chief Medical Officer |
Charles Duncan | Piper Jaffray |
Paul Matteis | Leerink |
Ian Somaiya | BMO Capital |
Jeff Meacham | Barclays |
Andrew Peters | Deutsche Bank |
Brian Skorney | Robert Baird |
Anupam Rama | JP Morgan |
Phil Nadeau | Cowen and Company |
Alan Carr | Needham & Company |
Jay Olson | Oppenheimer |
Biren Amin | Jefferies |
Good day, everyone, and welcome to Neurocrine Biosciences’ Reports Third Quarter 2017 Results. At this time, all participants are in a listen-only mode. Later you will have the opportunity to ask questions during the Q&A session. [Operator Instructions] Please note today’s call is being recorded and I will be standing by should you need any assistance. It is now my pleasure to turn the conference over to Kevin Gorman, CEO.